Katakura Industries Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Katakura Industries Co Ltd with three other
companies in this sector in Japan:
Aska Pharmaceutical Company Limited
sales of 43.22 billion Japanese Yen [US$388.50 million]
of which 90%
was Pharmaceutical Products Business),
Iwaki & Co., Ltd.
(55.12 billion Japanese Yen [US$495.55 million]
Fuso Pharmaceutical Industries Ltd
(45.75 billion Japanese Yen [US$411.31 million]
of which 100%
was Pharmaceutical Business).
Katakura Industries Co Ltd reported sales of ¥46.93 billion (US$421.87 million)
December of 2016.
decrease of 3.4%
versus 2015, when the company's sales were ¥48.57 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Katakura Industries Co Ltd had sales
of ¥47.79 billion.
Contributing to the drop in overall sales was the 25.3% decline
in Machinery-Related, from ¥12.61 billion to ¥9.41 billion.
There were also decreases in sales in
Fiber Business (down 0.2% to ¥9.64 billion)
However, these declines were partially offset by the increase in sales of
Pharmaceutical Products (up 1.1% to ¥15.07 billion)
Real Estate (up 13.4% to ¥10.19 billion)
Other (up 8.2% to ¥2.63 billion)